• Mineral levels closely approximating the mineral content of human milk (60:40 ratio of whey to casein)
  • Calcium-to-phosphorus ratio and content designed to manage serum calcium disorders—both hypercalcemia and hypocalcemia due to hyperphosphatemia
  • Gluten-free
  • Halal
  • Kosher
  • Gluten-free
  • 400-gram can

Similac PM 60/40 Low-Iron Infant Formula Powder

Please select a variation to view pricing options.

First Delivery: April 04, 2025 - April 05, 2025

Save 30% now on 1st Autoship*, 5% on repeat orders

  • Email reminder 3 days before it ships
  • Delay or cancel anytime

View Questions

(30% off first Autoship order*)

$34.99$140.90

About Similac PM 60/40 Low-Iron Infant Formula Powder

Similac PM 60/40 is a specialized infant formula designed to provide balanced nutrition for infants who require reduced mineral intake. With a carefully adjusted calcium-to-phosphorus ratio, this 20 Cal/fl oz formula helps manage serum calcium disorders, including hypercalcemia and hypocalcemia due to hyperphosphatemia, making it suitable for infants with impaired renal function.


Key Benefits & Features

  • Specialized Nutrition: Tailored for infants requiring reduced mineral intake.
  • Human-Milk-Inspired Mineral Content: Mineral levels are closely aligned with those found in human milk, featuring a 60:40 whey-to-casein ratio.
  • Serum Calcium Management: Designed to address serum calcium disorders, including hypercalcemia and hypocalcemia related to hyperphosphatemia.
  • Dietary-Friendly: Gluten-free, Halal, and Kosher certified, made with high-quality dairy ingredients.
  • Safe Use: For oral or tube feeding only; not suitable for intravenous use.

Similac PM 60/40 provides targeted nutrition to support your infant’s unique dietary needs while ensuring safety and quality.

Additional information
Select Options

14.1 oz – 1 Each

,

14.1 oz – Case of 6

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Similac PM 60/40 Low-Iron Infant Formula Powder”

Your email address will not be published. Required fields are marked *